Literature DB >> 16524671

Oncogenes, self-renewal and cancer.

Michael F Clarke1.   

Abstract

Cancers arise in a tissue as the culmination of a series of mutations that activate oncogenes and inactivate tumor suppressor genes. Many of these mutations affect cell proliferation and survival. Recently, it has become apparent that some oncogenes and tumor suppressor genes also regulate self-renewal, the process by which stem cells maintain themselves. In some cancer cells, the process of self-renewal is de-regulated resulting in expansion of these cells and tumors. It is likely that targeting cancer cell self-renewal pathways will result in more effective cancer therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16524671     DOI: 10.1016/j.patbio.2006.01.004

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

Review 1.  Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Authors:  Yunyi Kong; Suresh M Kumar; Xiaowei Xu
Journal:  Arch Pathol Lab Med       Date:  2010-12       Impact factor: 5.534

2.  Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.

Authors:  Patricia M McGowan; Carmen Simedrea; Emeline J Ribot; Paula J Foster; Diane Palmieri; Patricia S Steeg; Alison L Allan; Ann F Chambers
Journal:  Mol Cancer Res       Date:  2011-06-10       Impact factor: 5.852

3.  Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.

Authors:  Su-Feng Chen; Shin Nieh; Shu-Wen Jao; Chia-Lin Liu; Chien-Hua Wu; Yun-Ching Chang; Chin-Yuh Yang; Yaoh-Shiang Lin
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

4.  Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.

Authors:  Marta Rodríguez; Javier Silva; Alberto Herrera; Mercedes Herrera; Cristina Peña; Paloma Martín; Beatriz Gil-Calderón; María Jesús Larriba; M Josés Coronado; Beatriz Soldevilla; Víctor S Turrión; Mariano Provencio; Antonio Sánchez; Félix Bonilla; Vanesa García-Barberán
Journal:  Oncotarget       Date:  2015-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.